Resmed 

$236.88
580
-$5.73-2.36%Thursday 21:00
-$0.51-0.22%00:59After hours

Statistics

Day High
242.99
Day Low
236.03
52W High
277.67
52W Low
180.27
Volume
1,139,572
Avg. Volume
1,310,670
Mkt Cap
33.32B
P/E Ratio
19.64
Dividend Yield
1.11%
Dividend
2.64

Upcoming

Dividends

1.11%Dividend Yield
Dec 2026
$0.66
Sep 2026
$0.66
Jun 2026
$0.60
Mar 2026
$0.60
Dec 2025
$0.60
10Y Growth
7.18%
5Y Growth
9.12%
3Y Growth
10.97%
1Y Growth
12.33%

Earnings

Jan 28Expected
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Next
2.52
2.68
2.84
3
Expected EPS
2.995537
Actual EPS
N/A

Financials

26.94%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
5.65BRevenue
1.52BNet Income

Analyst Ratings

$246.11Average Price Target
The highest estimate is ⁦288.00⁩.
From 10 ratings within the last 6 months. This is not an investment recommendation.
Buy
30%
Hold
70%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RMD. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Koninklijke Philips N.V.
PHG
Mkt Cap29.66B
Philips Respironics, a subsidiary of Philips, competes directly with ResMed in the sleep and respiratory care market, offering CPAP machines, ventilators, and other respiratory products.
Fisher & Paykel Healthcare Limited
FPH.NZ
Mkt Cap0
Fisher & Paykel Healthcare is a leading manufacturer of respiratory care products, including CPAP devices and humidifiers, directly competing with ResMed's product offerings.
Medtronic
MDT
Mkt Cap131.57B
Medtronic offers a range of medical devices that compete with ResMed, particularly in the ventilation and monitoring systems for respiratory conditions.
Boston Scientific
BSX
Mkt Cap64.27B
Boston Scientific competes with ResMed in the medical device sector, particularly in areas of sleep and respiratory care through its various healthcare solutions.
GE Aerospace
GE
Mkt Cap344.27B
General Electric, through its healthcare division, provides medical devices and technologies that compete with ResMed's offerings, including respiratory care and sleep solutions.
Smith & Nephew
SNN
Mkt Cap13.09B
Smith & Nephew, while primarily known for orthopedics, competes with ResMed through its products in the medical equipment sector, including devices for wound management that can intersect with care for sleep-related conditions.
Stryker
SYK
Mkt Cap117.88B
Stryker competes with ResMed in the broader medical technology and devices market, offering products that can be used in surgical and critical care settings which may overlap with ResMed's market.
Zimmer Biomet
ZBH
Mkt Cap19.53B
Zimmer Biomet, primarily focused on musculoskeletal healthcare, competes with ResMed in the medical device market, offering products that can indirectly affect sleep and respiratory health.
Intuitive Surgical
ISRG
Mkt Cap153.77B
Intuitive Surgical, known for its robotic surgical systems, competes with ResMed in the broader healthcare technology space, offering innovative solutions that can impact the treatment of conditions related to sleep and respiratory care.

About

ResMed makes continuous positive airway pressure devices and the masks used to treat obstructive sleep apnea, a condition in which the airway repeatedly collapses during sleep. Devices make up about half of revenue, masks and accessories close to 40%, and residential care software the remainder. Growth depends on diagnosing more of the large untreated sleep apnea population and moving them onto therapy. The Americas contribute about two-thirds of device and mask revenue, with most of the rest from Europe, Japan, and Australia.
Show More
CEO
Michael J. Farrell
Employees
11370
Country
United States
ISIN
US7611521078
WKN
000895878

Listings

0 Comments

Share your thoughts

FAQs

What is Resmed stock price today?▼
The current price of RMD is $236.88 USD — it has decreased by -2.36% in the past 24 hours. Watch Resmed stock price performance more closely on the chart.
What is Resmed stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Resmed stocks are traded under the ticker RMD.
Is Resmed stock price growing?▼
RMD stock has fallen by -1.11% compared to the previous week, the month change is a -3.51% fall, over the last year Resmed has showed a -2.89% decrease.
What is Resmed market cap?▼
Today Resmed has the market capitalization of 33.32B
When is the next Resmed earnings date?▼
Resmed is going to release the next earnings report on January 28, 2027.
What were Resmed earnings last quarter?▼
RMD earnings for the last quarter are 2.91 USD per share, whereas the estimation was 2.69 USD resulting in a +8.33% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Resmed revenue for the last year?▼
Resmed revenue for the last year amounts to 5.65B USD.
What is Resmed net income for the last year?▼
RMD net income for the last year is 1.52B USD.
Does Resmed pay dividends?▼
Yes, RMD dividends are paid quarterly. The last dividend per share was 0.66 . As of today, Dividend Yield (FWD)% is 1.11%.
How many employees does Resmed have?▼
As of November 20, 2026, the company has 11,370 employees.
In which sector is Resmed located?▼
Resmed operates in the Health & Wellness sector.
When did Resmed complete a stock split?▼
The last stock split for Resmed was on August 31, 2010 with a ratio of 2:1.
Where is Resmed headquartered?▼
Resmed is headquartered in SAN DIEGO, United States.